Evidence map›Paper›PMID 19208634›Full record

ArticleThe Journal of biological chemistry2009

Leptin-dependent phosphorylation of PTEN mediates actin restructuring and activation of ATP-sensitive K+ channels.

Ke Ning, Lisa C Miller, Hilary A Laidlaw, Kenneth R Watterson, Jennifer Gallagher, Calum Sutherland, Michael L J Ashford

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Role of Protein Kinase CK2 in Aberrant Lipid Metabolism in Cancer.Pharmaceuticals (Basel, Switzerland) · 2020
    Review
  5. Leptin-induced Trafficking of KInternational journal of molecular sciences · 2019
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis.American journal of physiology. Regulatory, integrative and comparative physiology · 2014
    Review
  11. Advanced pharmacotherapy evidenced by pathogenesis of autism spectrum disorder.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2014
    Review
  12. Leptin regulation of hippocampal synaptic function in health and disease.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2014
    Review
  13. Article
  14. PTEN modulators: a patent review.Expert opinion on therapeutic patents · 2013
    Review
  15. Article
  16. Article
  17. Article
  18. What Are the bona fide GSK3 Substrates?International journal of Alzheimer's disease · 2011
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ke NingBiomedical Research Institute, Ninewells Hospital and Medical School, University of Dundee, Dundee DD1 9SY, United Kingdom.
Lisa C Miller
Hilary A Laidlaw
Kenneth R Watterson
Jennifer Gallagher
Calum Sutherland
Michael L J Ashford
University of Dundee · GBNinewells Hospital · GB

Funding

Biotechnology and Biological Sciences Research CouncilWellcome Trust 068692
6 · The paper itself

Abstract

Leptin activates multiple signaling pathways in cells, including the phosphatidylinositol 3-kinase pathway, indicating a degree of cross-talk with insulin signaling. The exact mechanisms by which leptin alters this signaling pathway and how it relates to functional outputs are unclear at present. A previous study has established that leptin inhibits the activity of the phosphatase PTEN (phosphatase and tensin homolog deleted on chromosome 10), an important tumor suppressor and modifier of phosphoinositide signaling. In this study we demonstrate that leptin phosphorylates multiple sites on the C-terminal tail of PTEN in hypothalamic and pancreatic beta-cells, an action not replicated by insulin. Inhibitors of the protein kinases CK2 and glycogen synthase kinase 3 (GSK3) block leptin-mediated PTEN phosphorylation. PTEN phosphorylation mutants reveal the critical role these sites play in transmission of the leptin signal to F-actin depolymerization. CK2 and GSK3 inhibitors also prevent leptin-mediated F-actin depolymerization and consequent ATP-sensitive K(+) channel opening. GSK3 kinase activity is inhibited by insulin but not leptin in hypothalamic cells. Both hormones increase N-terminal GSK3 serine phosphorylation, but in hypothalamic cells this action of leptin is transient. Leptin, not insulin, increases GSK3 tyrosine phosphorylation in both cell types. These results demonstrate a significant role for PTEN in leptin signal transmission and identify GSK3 as a potential important signaling node contributing to divergent outputs for these hormones.

Indexed as

ActinsAdenosine TriphosphateAmino Acid SequenceAnimalsCasein Kinase IICell LineEnzyme ActivationLeptinMiceMice, Inbred C57BLMolecular Sequence DataMutationPhosphatidylinositol 3-KinasesPhosphorylationPotassium ChannelsPTEN PhosphohydrolaseActinsAdenosine TriphosphateCasein Kinase IILeptinPhosphatidylinositol 3-KinasesPotassium ChannelsPTEN PhosphohydrolasePten protein, mouse

Identifiers

PMID19208634
PMCPMC2666585
OpenAlexW2071936975

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.